Michael P Waalkes Selected Research

Michael P Waalkes Research Topics

Disease

82	Neoplasms (Cancer) 04/2020 - 08/2002
52	Carcinogenesis 04/2020 - 12/2002
15	Hepatocellular Carcinoma (Hepatoma) 03/2012 - 01/2004
9	Prostatic Neoplasms (Prostate Cancer) 12/2016 - 12/2002
9	Carcinoma (Carcinomatosis) 08/2014 - 05/2004
9	Skin Neoplasms (Skin Cancer) 01/2012 - 01/2004
9	Arsenic Poisoning 09/2006 - 02/2002
8	Lung Neoplasms (Lung Cancer) 07/2015 - 12/2003
8	Hyperplasia 03/2012 - 01/2004
7	Adenoma (Adenomas) 08/2014 - 11/2004
5	Necrosis 06/2013 - 05/2002
5	Inflammation (Inflammations) 04/2013 - 07/2004
5	Adenocarcinoma of Lung 08/2012 - 09/2006
5	Papilloma (Papillomatosis) 05/2010 - 08/2004
4	Body Weight (Weight, Body) 11/2012 - 01/2004
3	Breast Neoplasms (Breast Cancer) 02/2014 - 05/2005
3	Adenocarcinoma 01/2012 - 12/2003
3	Liver Neoplasms (Liver Cancer) 10/2011 - 05/2008
3	Adrenocortical Adenoma (Disease, Conn's) 05/2010 - 09/2006
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2009 - 09/2008
3	Fibrosis (Cirrhosis) 09/2008 - 02/2006
3	Liver Cirrhosis (Hepatic Cirrhosis) 03/2008 - 02/2003
3	Fibrosarcoma 07/2005 - 01/2004
2	Neoplasm Metastasis (Metastasis) 04/2014 - 05/2005
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2012 - 03/2005
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2012 - 11/2004
1	Insulin Resistance 10/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2015
1	Hyperglycemia 10/2015
1	Leiomyoma (Uterine Fibroids) 04/2015
1	Melanoma (Melanoma, Malignant) 01/2015
1	Birth Weight (Birth Weights) 08/2014

Drug/Important Bio-Agent (IBA)

69	ArsenicIBA 04/2020 - 02/2002
18	CarcinogensIBA 01/2017 - 01/2003
16	CadmiumIBA 01/2017 - 08/2002
15	arseniteIBA 12/2009 - 05/2002
13	Drinking WaterIBA 03/2011 - 01/2003
9	Proteins (Proteins, Gene)FDA Link 01/2015 - 02/2004
8	Arsenicals (Arsenic Compounds)IBA 11/2012 - 08/2004
7	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2003
6	Estrogens (Estrogen)FDA Link 04/2015 - 03/2004
6	MetallothioneinIBA 12/2013 - 07/2004
5	sodium arsenite (sodium metaarsenite)IBA 07/2015 - 02/2004
5	Matrix Metalloproteinases (MMPs)IBA 02/2014 - 12/2009
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2008 - 02/2004
5	AndrogensIBA 02/2008 - 10/2004
4	MetalsIBA 01/2018 - 07/2004
4	Biomarkers (Surrogate Marker)IBA 12/2016 - 10/2007
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2015 - 07/2003
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2012 - 12/2002
4	Cyclin D1IBA 09/2011 - 02/2004
4	Diethylstilbestrol (Stilbestrol)FDA Link 12/2009 - 02/2006
4	EnzymesIBA 09/2009 - 07/2005
3	Estrogen ReceptorsIBA 04/2015 - 01/2011
3	AgarIBA 01/2013 - 08/2009
3	Cacodylic Acid (Cacodylate)IBA 03/2012 - 02/2006
3	Tamoxifen FDA LinkGeneric 08/2007 - 02/2006
3	Keratin-18 (Keratin 18)IBA 10/2006 - 02/2004
3	Estrogen Receptor alphaIBA 09/2006 - 02/2006
3	O(2)- vinyl- 1- (pyrrolidin- 1- yl)diazen- 1- ium- 1,2- diolateIBA 07/2005 - 08/2003
3	NickelIBA 07/2005 - 01/2004
2	matrigelIBA 08/2013 - 01/2013
2	LeptinIBA 06/2013 - 04/2013
2	monomethylarsonic acid (MSMA)IBA 06/2012 - 08/2005
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2009 - 03/2005
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 09/2008 - 02/2007
2	Arsenic Trioxide (Trisenox)FDA Link 08/2008 - 08/2004
2	Interleukin-6 (Interleukin 6)IBA 03/2008 - 07/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2008 - 10/2006
2	Cadmium CompoundsIBA 04/2007 - 10/2004
2	Coal (Coals)IBA 09/2006 - 02/2002
2	Cisplatin (Platino)FDA LinkGeneric 07/2006 - 06/2004
2	Glutathione (Reduced Glutathione)IBA 06/2006 - 06/2004
2	TransferasesIBA 06/2006 - 06/2004
2	AcetoneIBA 06/2006 - 01/2004
2	Complementary DNA (cDNA)IBA 05/2005 - 08/2004
2	Phorbol EstersIBA 05/2004 - 01/2004
1	Glucose (Dextrose)FDA LinkGeneric 10/2015
1	Insulin (Novolin)FDA Link 10/2015
1	Triglycerides (Triacylglycerol)IBA 10/2015
1	LDL CholesterolIBA 10/2015
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 07/2015
1	ATP dependent 26S protease (26S proteasome)IBA 01/2015
1	CamptothecinIBA 01/2015
1	UbiquitinIBA 01/2015
1	PoisonsIBA 01/2015
1	Etoposide (VP 16)FDA LinkGeneric 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2015
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2015
1	trioctyl phosphine oxide (TOPO)IBA 01/2015
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2015
1	MicroRNAs (MicroRNA)IBA 04/2014
1	Aromatase InhibitorsIBA 02/2014
1	monomethylarsonous acidIBA 02/2014
1	Aromatase (CYP19)IBA 02/2014
1	Endocrine DisruptorsIBA 02/2014
1	Letrozole (Femara)FDA LinkGeneric 02/2014

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 03/2009 - 06/2003
3	Therapeutics 09/2006 - 02/2006